140223-15-0

Basic information

• Product Name: 1,2,3,4-Tetra-O-benzoyl-L-fucopyranose
• Synonyms: 1,2,3,4-Tetra-O-benzoyl-L-fucose;6-Deoxy-L-galactopyranose 1,2,3,4-Tetrabenzoate
• CAS NO: 140223-15-0
• Molecular Formula: C₃₄H₂₈O₉
• Molecular Weight: 580.58
• Product Categories: Carbohydrates & Derivatives
• Mol File: 140223-15-0.mol
• Article Data: 25

Chemical Properties

• Appearance: /
• Stability: Store in Freezer
• CAS DataBase Reference: 1,2,3,4-Tetra-O-benzoyl-L-fucopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-Tetra-O-benzoyl-L-fucopyranose(140223-15-0)
• EPA Substance Registry System: 1,2,3,4-Tetra-O-benzoyl-L-fucopyranose(140223-15-0)

Safety Data

• Hazardous Substances Data: 140223-15-0(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

1,2,3,4-Tetra-O-benzoyl-L-fucopyranose (cas# 140223-15-0) is a compound useful in organic synthesis.

Upstream product

• 6155-35-7 L-rhamnose monohydrate 
• 98-88-4 benzoyl chloride 
• 3615-41-6 L-Rhamnose 
• 73-34-7 L-rhamnose 
• 73-34-7 6-deoxy-L-galactose 
• 2438-80-4 L-Fucose 
• 6130-58-1 kaempferol-3-rutinoside 
• 6014-42-2 L-rhamnose 
• 1326303-82-5 4',4''',5,5'',7,7''-hexahydroxy-3,3''-O-rutinosyl-3',3'''-bisflavonoyl ether 

Downstream Products

• 15356-10-2 1,1-bis-benzoylamino-1,6-dideoxy-L-mannitol 
• 32442-84-5 N-benzoyl-ξ-L-rhamnopyranosylamine 
• 146934-34-1 2,3,4-Tri-O-benzoyl-α-L-rhamnopyranosyl chloride 
• 14218-08-7 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl bromide 
• 511548-70-2 tri-O-benzoyl-α-L-rhamnopyranosyl iodide 
• 73068-86-7 p-tolyl 2,3-O-isopropylidene-1-thio-α-L-rhamnopyranoside 
• 161007-95-0 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyltrichloroacetimidate 
• 340964-54-7 allyl 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl-(1->6)-3,4-di-O-benzoyl-α-D-glucopyranoside 
• 85597-39-3 1,2-di-O-acetyl-3,4-di-O-benzoyl-L-rhamnopyranose 
• 85572-70-9 3,4-di-O-benzoyl-1,2-O-benzylidene-β-L-rhamnopyranose 
• 1218904-51-8 2,3,4-tri-O-benzoyl-α-L-fucopyranosyl iodide 
• 1372616-12-0 benzyl-2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl-(1→2)-3,4-O-isopropylidene-α-L-arabinopyranoside 

Relevant articles and documents

Boronic acid-catalyzed final-stage site-selective acylation for the total syntheses of O-3′-acyl bisabolol β-D-fucopyranoside natural products and their analogues

The first concise total syntheses of O-3′-senecioyl α-bisabolol β-D-fucopyranoside (4a) and O-3′isovaleroyl α-bisabolol β-D-fucopyranoside (4b) were achieved through final-stage site-selective acylation via the activation of cis-vicinal diols by imidazole

Sterically Hindered 2,4,6-Tri- tert-butylpyridinium Salts as Single Hydrogen Bond Donors for Highly Stereoselective Glycosylation Reactions of Glycals

We demonstrate here that the strained and bulky protonated 2,4,6-tri-tert-butylpyridine salts serve as efficient catalysts for highly stereoselective glycosylations of various glycals. Moreover, the mechanism of action involves an interesting single hydrogen bond mediated protonation of glycals and not via the generally conceived Br?nsted acid pathway. The counteranions also play a role in the outcome of the reaction.

BIARYL AMIDES WITH MODIFIED SUGAR GROUPS FOR TREATMENT OF DISEASES ASSOCIATED WITH HEAT SHOCK PROTEIN PATHWAY

Provided are biaryl amides and coumarin-based compounds with modified sugar groups for treatment of diseases associated with heat shock protein pathway. The compounds having the following formulas, wherein variables are as defined herein. Formulae (I), (II), (III), (IV), and (V), Pharmaceutical compositions of the compounds are also provided. These biaryl amides and coumarin-based derivatives with modified sugar groups are useful for treatment and prevention of diseases and disorders, including neurological disorders, such as neurodegenerative diseases and nerve damaging disorders, for example, diabetic peripheral neuropathy.